Last reviewed · How we verify
Placebo to ZSP1273
Placebo to ZSP1273 is a SGLT2 inhibitor Small molecule drug developed by Guangdong Raynovent Biotech Co., Ltd. It is currently in Phase 3 development for Type 2 diabetes.
ZSP1273 is a small molecule that acts as a selective and potent inhibitor of the sodium-glucose cotransporter 2 (SGLT2).
ZSP1273 is a small molecule that acts as a selective and potent inhibitor of the sodium-glucose cotransporter 2 (SGLT2). Used for Type 2 diabetes.
At a glance
| Generic name | Placebo to ZSP1273 |
|---|---|
| Sponsor | Guangdong Raynovent Biotech Co., Ltd |
| Drug class | SGLT2 inhibitor |
| Target | SGLT2 |
| Modality | Small molecule |
| Therapeutic area | Diabetes |
| Phase | Phase 3 |
Mechanism of action
By inhibiting SGLT2, ZSP1273 reduces glucose reabsorption in the kidneys, leading to increased glucose excretion in the urine and lowering blood glucose levels. This mechanism is particularly beneficial for patients with type 2 diabetes.
Approved indications
- Type 2 diabetes
Common side effects
- Increased risk of diabetic ketoacidosis
- Genital amputation
- Increased risk of acute kidney injury
Key clinical trials
- A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A (PHASE3)
- The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo to ZSP1273 CI brief — competitive landscape report
- Placebo to ZSP1273 updates RSS · CI watch RSS
- Guangdong Raynovent Biotech Co., Ltd portfolio CI
Frequently asked questions about Placebo to ZSP1273
What is Placebo to ZSP1273?
How does Placebo to ZSP1273 work?
What is Placebo to ZSP1273 used for?
Who makes Placebo to ZSP1273?
What drug class is Placebo to ZSP1273 in?
What development phase is Placebo to ZSP1273 in?
What are the side effects of Placebo to ZSP1273?
What does Placebo to ZSP1273 target?
Related
- Drug class: All SGLT2 inhibitor drugs
- Target: All drugs targeting SGLT2
- Manufacturer: Guangdong Raynovent Biotech Co., Ltd — full pipeline
- Therapeutic area: All drugs in Diabetes
- Indication: Drugs for Type 2 diabetes
- Compare: Placebo to ZSP1273 vs similar drugs
- Pricing: Placebo to ZSP1273 cost, discount & access